Company intelligence / Profile preview
Yantai Dongcheng Pharmaceutical Group
Yantai, Shandong, Chinadcb-group.com ↗
- Ownership
- Private
- Employees
- ~2469
- Development stage
- Other
01
Overview
Yantai Dongcheng is a leading Chinese pharmaceutical group specializing in the manufacture and export of biochemical APIs such as heparin sodium and chondroitin sulfate, with significant regulatory certifications including U.S. FDA site audit and European CEP certificates[4][6][8]. The company has expanded into radiopharmaceuticals and finished formulations, with products sold in over 50 countries[4][6].
- Therapeutic areas
- OncologyCardiovascularRheumatologyInfectious Diseases
- Modalities
- Small moleculeProteinPolysaccharide (e.g. heparin, chondroitin sulfate)Radiopharmaceutical
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Long-term cooperation with international pharmaceutical companies and dietary supplement manufacturers[3]
Beyond the preview
Go deeper on Yantai Dongcheng Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yantai Dongcheng Pharmaceutical Group.